Podocyte globotriaosylceramide (GL-3) content in male adult patients with Fabry disease reduces following 6-12 months of treatment with migalastat
Najafian, Behzad, Sokolovskiy, Alexey, Barth, Jay, Castelli, Jeff, Williams, Hadis, Mauer, MichaelVolume:
117
Language:
english
Journal:
Molecular Genetics and Metabolism
DOI:
10.1016/j.ymgme.2015.12.374
Date:
February, 2016
File:
PDF, 46 KB
english, 2016